866-997-4948(US-Canada Toll Free)

Peripheral Embolic Protection Devices-Medical Devices Pipeline Assessment, 2019

Published By :

GlobalData

Published Date : Dec 2019

Category :

Medical Equipments

No. of Pages : 104 Pages

Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Peripheral Embolic Protection Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Embolic Protection Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Peripheral Embolic Protection Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Peripheral Embolic Protection Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Peripheral Embolic Protection Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date
Table of Contents
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Peripheral Embolic Protection Devices Overview 7
3 Products under Development 8
3.1 Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development 8
3.2 Peripheral Embolic Protection Devices - Pipeline Products by Segment 9
3.3 Peripheral Embolic Protection Devices - Pipeline Products by Territory 10
3.4 Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path 11
3.5 Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date 12
3.6 Peripheral Embolic Protection Devices - Ongoing Clinical Trials 13
4 Peripheral Embolic Protection Devices - Pipeline Products under Development by Companies 14
4.1 Peripheral Embolic Protection Devices Companies - Pipeline Products by Stage of Development 14
4.2 Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development 15
5 Peripheral Embolic Protection Devices Companies and Product Overview 16
5.1 Abbott Vascular Inc Company Overview 16
5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 Artio Medical Company Overview 17
5.2.1 Artio Medical Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 Avantec Vascular Corp Company Overview 18
5.3.1 Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview 18
5.4 BTG Plc Company Overview 19
5.4.1 BTG Plc Pipeline Products & Ongoing Clinical Trials Overview 19
5.5 Capture Vascular Inc Company Overview 20
5.5.1 Capture Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 20
5.6 Cardio-Flow Ltd. Company Overview 22
5.6.1 Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview 22
5.7 Cardiovascular Systems Inc Company Overview 23
5.7.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 23
5.8 Emboline, Inc. Company Overview 25
5.8.1 Emboline, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.9 Filterlex Medical Ltd Company Overview 28
5.9.1 Filterlex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 28
5.10 Innovative Cardiovascular Solutions, LLC Company Overview 29
5.10.1 Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview 29
5.11 Innovia LLC Company Overview 32
5.11.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 32
5.12 Javelin Medical Ltd Company Overview 33
5.12.1 Javelin Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
5.13 Keystone Heart Ltd Company Overview 36
5.13.1 Keystone Heart Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
5.14 Medtronic plc Company Overview 38
5.14.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 38
5.15 MIV Therapeutics Inc Company Overview 39
5.15.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 39
5.16 Neurosonix Ltd. Company Overview 40
5.16.1 Neurosonix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40
5.17 Protembis GmbH Company Overview 41
5.17.1 Protembis GmbH Pipeline Products & Ongoing Clinical Trials Overview 41
5.18 University of Minnesota Company Overview 42
5.18.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 42
5.19 University of Toledo Company Overview 43
5.19.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 43
6 Peripheral Embolic Protection Devices- Recent Developments 44
6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 44
6.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 46
6.3 Nov 07, 2019: Penumbra reports third quarter 2019 financial results 47
6.4 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 48
6.5 Oct 23, 2019: Edwards Lifesciences reports third quarter results 50
7 Appendix 101
7.1 Methodology 101
7.2 About GlobalData 104
7.3 Contact Us 104
7.4 Disclaimer 104

List of Tables
Table 1: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
Table 2: Peripheral Embolic Protection Devices - Pipeline Products by Segment
Table 3: Peripheral Embolic Protection Devices - Pipeline Products by Territory
Table 4: Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path
Table 5: Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date
Table 6: Peripheral Embolic Protection Devices - Ongoing Clinical Trials
Table 7: Peripheral Embolic Protection Devices Companies - Pipeline Products by Stage of Development
Table 8: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
Table 9: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Status
Table 11: Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Description
Table 12: Artio Medical Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Blockstent Microcatheter - Product Status
Table 14: Blockstent Microcatheter - Product Description
Table 15: Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Peripheral Embolization Device - Product Status
Table 17: Peripheral Embolization Device - Product Description
Table 18: BTG Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 19: EKOS Control Unit - New - Product Status
Table 20: EKOS Control Unit - New - Product Description
Table 21: Capture Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Megavac - BTK - Product Status
Table 23: Megavac - BTK - Product Description
Table 24: Thrombowire Clot Retractor - BTK - Product Status
Table 25: Thrombowire Clot Retractor - BTK - Product Description
Table 26: Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 27: EmboPRO EPD - Product Status
Table 28: EmboPRO EPD - Product Description
Table 29: Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: WIRION EPD System - LE Atherectomy - Product Status
Table 31: WIRION EPD System - LE Atherectomy - Product Description
Table 32: Emboline, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Emboliner - Product Status
Table 34: Emboliner - Product Description
Table 35: Emboline, Inc. - Ongoing Clinical Trials Overview
Table 36: Emboliner - A Prospective, Non-randomized, Multi-center, Open-label Clinical Investigation to Assess the Safety and Technical Performance of the Emboliner Embolic Protection Catheter
Table 37: Filterlex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 38: CAPTIS - Product Status
Table 39: CAPTIS - Product Description
Table 40: Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 41: EMBLOK Embolic Protection System - Product Status
Table 42: EMBLOK Embolic Protection System - Product Description
Table 43: Innovative Cardiovascular Solutions, LLC - Ongoing Clinical Trials Overview
Table 44: EMBLOK Embolic Protection System - European Study Evaluating the EMBLOK Cerebral Embolic Protection System During Transcatheter Aortic Valve Replacement (TAVR)
Table 45: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Permanently Implantable Embolic Balloon - Product Status
Table 47: Permanently Implantable Embolic Balloon - Product Description
Table 48: Javelin Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 49: Vine - Product Status
Table 50: Vine - Product Description
Table 51: Javelin Medical Ltd - Ongoing Clinical Trials Overview
Table 52: Vine - Carotid Artery Implant for Trapping Upstream Emboli (CAPTURE 2) for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants
Table 53: Vine - Carotid Artery Implant for Trapping Upstream Emboli for Preventing Stroke in Atrial Fibrillation Patients
Table 54: Keystone Heart Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 55: TriGuard 3 - Product Status
Table 56: TriGuard 3 - Product Description
Table 57: TriGuard Cerebral Protection Device - Product Status
Table 58: TriGuard Cerebral Protection Device - Product Description
Table 59: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview

List of Figures
Figure 1: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
Figure 2: Peripheral Embolic Protection Devices - Pipeline Products by Segment
Figure 3: Peripheral Embolic Protection Devices - Pipeline Products by Territory
Figure 4: Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path
Figure 5: Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date
Figure 6: Peripheral Embolic Protection Devices - Ongoing Clinical Trials

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *